JP Morgan Chase
JAZZ icon

JP Morgan Chase’s Jazz Pharmaceuticals JAZZ Stock Holding History

JP Morgan Chase’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-27,200
Closed -$3.35M – 7642
2023
Q4 		$3.35M Buy
+27,200
New +$3.39M ﹤0.01% 3435
2021
Q2 		– Sell
-25,000
Closed -$4.11M – 6464
2021
Q1 		$4.11M Sell
25,000
-40,000
-62% -$6.58M ﹤0.01% 3140
2020
Q4 		$10.7M Buy
65,000
+32,600
+101% +$4.86M ﹤0.01% 2157
2020
Q3 		$4.53M Buy
+32,400
New +$4.02M ﹤0.01% 2650
2018
Q3 		– Sell
-70,000
Closed -$12.1M – 5736
2018
Q2 		$12.1M Buy
70,000
+30,000
+75% +$4.9M ﹤0.01% 1987
2018
Q1 		$6.04M Buy
+40,000
New +$5.87M ﹤0.01% 2413
2017
Q4 		– Sell
-30,000
Closed -$4.44M – 5505
2017
Q3 		$4.44M Buy
+30,000
New +$4.54M ﹤0.01% 2646
2017
Q2 		– Sell
-27,000
Closed -$3.92M – 5083
2017
Q1 		$3.92M Buy
+27,000
New +$3.52M ﹤0.01% 2608
2015
Q3 		– Sell
-2,675
Closed -$471K – 3997
2015
Q2 		$471K Sell
2,675
-27,325
-91% -$4.91M ﹤0.01% 3577
2015
Q1 		$5.18M Buy
+30,000
New +$5.15M ﹤0.01% 2324
2014
Q4 		– Sell
-910,000
Closed -$146M – 4285
2014
Q3 		$146M Buy
+910,000
New +$140M 0.03% 500

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

JP Morgan Chase's JAZZ Position: Q1 2026 in Review

JP Morgan Chase increased its Jazz Pharmaceuticals (JAZZ) stake by 15% in Q1 2026, buying an estimated $27.9M and bringing the position to 1,204,353 shares worth $221M. The position accounts for 0.01% of the portfolio, ranked #658.

JP Morgan Chase first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $527M in Q2 2022. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • JP Morgan Chase held 1,204,353 shares of Jazz Pharmaceuticals worth $221M as of Q1 2026.
  • JP Morgan Chase bought 159,711 Jazz Pharmaceuticals shares in Q1 2026, an estimated $27.9M.
  • Jazz Pharmaceuticals made up 0.01% of JP Morgan Chase's portfolio in Q1 2026, its #658 holding.
  • JP Morgan Chase first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Jazz Pharmaceuticals position peaked at $527M in Q2 2022.
  • 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.